Back

Rates of implantable cardioverter defibrillator implantation and outcomes in octogenarians or older compared to non-octogenarians in a statewide cohort from 2009 - 2018

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Successful outcomes in device therapy Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Vijayatubini Vijayarajan

Concord General Repatriation Hospital, Concord West (Australia)

6 More presentations in this session

Presentation thumbnail
Safety and effectiveness of His-bundle pacing and left bundle branch pacing (conduction system pacing) as a first option for cardiac pacing - results of a single-center
Mr C. Slater (Rio de Janeiro, BR)
Abstract Slides
Presentation thumbnail
Comparison of septal vs hisian ventricular synchrony in paediatric patients
Doctor S. Pacheco (Guadalajara, MX)
Abstract Slides
Presentation thumbnail
A new window on subcutaneous icd system performance: Z-lead impedance change over time in devices with and without extracellular matrix envelope use
Doctor K. Liu (Jacksonville, US)
Abstract Slides
Presentation thumbnail
Effects of hyperbaric exposure on mechanical and electronic parameters of implantable cardioverter-defibrillators
Professor J. Mansourati (Brest, FR)
Abstract Slides
Presentation thumbnail
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors
Doctor M. Martinho (Almada, PT)
Abstract Slides

Access the full session

Session thumbnail
Successful outcomes in device therapy

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources